These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 25339844)

  • 21. Alcoholics Anonymous and other 12-step programs for alcohol use disorder.
    Kelly JF; Humphreys K; Ferri M
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012880. PubMed ID: 32159228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bidirectional relationships between alcohol, cannabis, co-occurring alcohol and cannabis use disorders with major depressive disorder: results from a national sample.
    Pacek LR; Martins SS; Crum RM
    J Affect Disord; 2013 Jun; 148(2-3):188-95. PubMed ID: 23260381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes.
    Clark DB; De Bellis MD; Lynch KG; Cornelius JR; Martin CS
    Drug Alcohol Depend; 2003 Jan; 69(1):51-60. PubMed ID: 12536066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disorder-specific versus transdiagnostic and clinician-guided versus self-guided treatment for major depressive disorder and comorbid anxiety disorders: A randomized controlled trial.
    Titov N; Dear BF; Staples LG; Terides MD; Karin E; Sheehan J; Johnston L; Gandy M; Fogliati VJ; Wootton BM; McEvoy PM
    J Anxiety Disord; 2015 Oct; 35():88-102. PubMed ID: 26422822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol use and depression during adolescence and young adulthood: a summary and interpretation of mixed findings.
    Pedrelli P; Shapero B; Archibald A; Dale C
    Curr Addict Rep; 2016 Mar; 3(1):91-97. PubMed ID: 27162708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis.
    Tang VM; Yu D; Weissman CR; Jones BDM; Wang G; Sloan ME; Blumberger DM; Daskalakis ZJ; Le Foll B; Voineskos D
    J Affect Disord; 2023 Oct; 339():691-697. PubMed ID: 37467796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and Efficacy of Delivering Cognitive Behavioral Therapy Through an Online Psychotherapy Tool for Depression: Protocol for a Randomized Controlled Trial.
    Alavi N; Stephenson C; Yang M; Kumar A; Shao Y; Miller S; Yee CS; Stefatos A; Gholamzadehmir M; Abbaspour Z; Jagayat J; Shirazi A; Omrani M; Patel A; Patel C; Groll D
    JMIR Res Protoc; 2021 Jun; 10(6):e27489. PubMed ID: 33990076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis.
    Riper H; Andersson G; Hunter SB; de Wit J; Berking M; Cuijpers P
    Addiction; 2014 Mar; 109(3):394-406. PubMed ID: 24304463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mirtazapine in comorbid major depression and an alcohol use disorder: A double-blind placebo-controlled pilot trial.
    Cornelius JR; Chung T; Douaihy AB; Kirisci L; Glance J; Kmiec J; FitzGerald D; Wesesky MA; Salloum I
    Psychiatry Res; 2016 Aug; 242():326-330. PubMed ID: 27327217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD).
    Elliott SJ; Marshall D; Morley K; Uphoff E; Kumar M; Meader N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013173. PubMed ID: 34693989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates of major depressive disorder with and without comorbid alcohol use disorder nationally in the veterans health administration.
    Yoon G; Petrakis IL; Rosenheck RA
    Am J Addict; 2015 Aug; 24(5):419-26. PubMed ID: 25950244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Major depression associated with earlier alcohol relapse in treated teens with AUD.
    Cornelius JR; Maisto SA; Martin CS; Bukstein OG; Salloum IM; Daley DC; Wood DS; Clark DB
    Addict Behav; 2004 Jul; 29(5):1035-8. PubMed ID: 15219354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can Cognitive-Behavioral Therapy Be Optimized With Parent Psychoeducation? A Randomized Effectiveness Trial of Adolescents With Major Depression in Puerto Rico.
    Bernal G; Rivera-Medina CL; Cumba-Avilés E; Reyes-Rodríguez ML; Sáez-Santiago E; Duarté-Vélez Y; Nazario L; Rodríguez-Quintana N; Rosselló J
    Fam Process; 2019 Dec; 58(4):832-854. PubMed ID: 31077610
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.